Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis.
Saved in:
| Title: | Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. |
|---|---|
| Authors: | Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Manley PW; Novartis Pharma AG, Basel, Switzerland; and., Larson RA; Department of Medicine, University of Chicago, Chicago, IL., Capdeville R; Novartis Pharma AG, Basel, Switzerland; and. |
| Source: | Blood advances [Blood Adv] 2018 Feb 27; Vol. 2 (4), pp. 444-453. |
| Publication Type: | Historical Article; Journal Article; Review |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29487059 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stone+RM%22">Stone RM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Manley+PW%22">Manley PW</searchLink>; Novartis Pharma AG, Basel, Switzerland; and.<br /><searchLink fieldCode="AU" term="%22Larson+RA%22">Larson RA</searchLink>; Department of Medicine, University of Chicago, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Capdeville+R%22">Capdeville R</searchLink>; Novartis Pharma AG, Basel, Switzerland; and. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2018 Feb 27; Vol. 2 (4), pp. 444-453. – Name: TypePub Label: Publication Type Group: TypPub Data: Historical Article; Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29487059 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2017011080 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 444 Titles: – TitleFull: Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stone RM – PersonEntity: Name: NameFull: Manley PW – PersonEntity: Name: NameFull: Larson RA – PersonEntity: Name: NameFull: Capdeville R IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 02 Text: 2018 Feb 27 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 2 – Type: issue Value: 4 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |